NCT04641468 is a NA clinical trial of DCB in Coronary Diseases, sponsored by Xuzhou Third People's Hospital.

Who is sponsoring NCT04641468?

NCT04641468 is sponsored by Xuzhou Third People's Hospital.

What drugs are being tested in NCT04641468?

Interventions in NCT04641468: DCB.

What condition does NCT04641468 study?

NCT04641468 studies Coronary Diseases, Left Main Coronary Artery Disease, Bifurcation Lesions.

Is NCT04641468 still recruiting?

NCT04641468 is currently status unknown. Last updated 27 November 2020.

Last reviewed 2020-11-27 · How we verify

NCT04641468

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Efficacy and Safety of a Prospective, Multicenter Drug Coated Balloon for Left Main Artery Disease in China

Status unknown NA Last updated 27 November 2020

What this trial tests

NA trial testing DCB in Coronary Diseases in 30 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
31 December 2020

31 December 2021

Quick facts

Lead sponsor	Xuzhou Third People's Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 November 2018
Primary completion	31 December 2020
Estimated completion	31 December 2021
Sites	1 location across China

Drugs / interventions tested

Conditions studied

Coronary Diseases — all drugs for Coronary Diseases →
Left Main Coronary Artery Disease — all drugs for Left Main Coronary Artery Disease →
Bifurcation Lesions — all drugs for Bifurcation Lesions →

Sponsor

Xuzhou Third People's Hospital

Who can join

Adults 18 to 75, any sex, with Coronary Diseases or Left Main Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective and observational study. Patients with primary mediana 010 or 001 left main bifurcation lesions were treated with drug ball coated balloon from November 2018 to November 2020 in four hospitals in Huaihai area. The clinical characteristics, pathological changes, operation process and perioperative drug treatment data were collected. Clinical follow-up included hospitalization, postoperative telephone or outpatient follow-up. Objective to compare the safety and efficacy of drug-eluting balloon and drug-eluting stent implantation alone in the treatment of primary mediana 010 or 001 left main bifurcation lesions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in <i>de novo</i> Lesions of Large Coronary Arteries.
Hu FW, Chang S, Li Q, Zhu YX, et al · · 2022 · cited 16× · PMID 35911516 · DOI 10.3389/fcvm.2022.882303

Verify or expand the search:

Other trials of DCB

Trials testing the same drug.

NCT06168422 — A Cohort Study of PCI Strategies for Severely Calcified Lesions of Complex Coronary Arteries in the Elderly · recruiting
NCT06047964 — SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis · NA · active not recruiting
NCT05750771 — Comparison of DCB and DES for Severe Calcification of de Novo Lesion in Elderly CHD · NA · completed
NCT02963649 — IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA · NA · completed

Other Xuzhou Third People's Hospital trials

Trials by the same sponsor.

NCT07162792 — The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT · NA · not yet recruiting
NCT06669195 — Intravascular Lithotripsy for Acute Stent Under-expansion in Calcified Coronary Lesions · NA · not yet recruiting
NCT06669793 — Biolimus-Coated Balloon in de Novo Large Vessel Coronary Lesions · NA · not yet recruiting
NCT06166459 — Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation Lesion · NA · unknown
NCT04375319 — OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS) · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04641468 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Xuzhou Third People's Hospital
Last refreshed: 27 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641468.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing